Cell Therapy Processing Market Report 2026

Cell Therapy Processing Market Overview

• Cell Therapy Processing market size has reached to $5.18 billion in 2025 • Expected to grow to $9.93 billion in 2030 at a compound annual growth rate (CAGR) of 13.8% • Growth Driver: Rising Cell Therapy Research Activities Fueling The Growth Of The Market Due To Increasing Demand For Scalable And High-Quality Cell Manufacturing Platforms • Market Trend: Technological Innovations In Cell Therapy Manufacturing Enhance Workflow Efficiency And Scalability • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Therapy Processing Market?

Cell therapy processing refers to the series of steps involved in collecting, modifying, and preparing living cells for therapeutic use. It includes cell isolation, activation, genetic modification, expansion, and formulation under strict sterile and quality-controlled conditions. These processes are performed in compliance with good manufacturing practices (GMP) to ensure safety, purity, and potency. The main offerings of cell therapy processing include products, services, and software. Products include the physical tools, reagents, cell lines, and advanced instruments needed for handling, cultivating, and preparing cells. It is applied for cardiovascular devices, bone repair, neurological disorders, skeletal muscle repair, cancer, and others by several end-users, including research institutes, biopharmaceutical companies, contract research organizations, and others.

What Is The Cell Therapy Processing Market Growth Forecast?

The cell therapy processing market size is expected to see rapid growth in the next few years. It will grow to $9.93 billion in 2030 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to increasing commercialization of gene and cell therapies, rising demand for contract manufacturing services, expansion of decentralized manufacturing models, growing adoption of digital quality management systems, increasing regulatory approvals for cell-based therapies. Major trends in the forecast period include increasing adoption of gmp-compliant processing platforms, rising demand for scalable cell therapy manufacturing, growing integration of workflow automation software, expansion of contract processing services, enhanced focus on sterility and quality assurance.

Global Cell Therapy Processing Market Segmentation

1) By Offering Type: Products, Services, Software 2) By Applications: Cardiovascular Diseases Or Cardiac Regenerative Therapies, Bone Repair, Neurological Disorders, Skeletal Muscle Repair, Cancer, Other Applications 3) By End-User: Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, Other End-Users Subsegments: 1) By Products: Cell Processing Systems, Cell Separation Devices, Cell Culture Equipment, Cell Preservation Systems, Consumables And Reagents 2) By Services: Contract Manufacturing Services, Process Development Services, Quality Control And Testing Services, Logistics And Supply Chain Services, Regulatory Compliance And Documentation Services 3) By Software: Cell Processing Workflow Management Software, Data Analysis And Reporting Software, Quality Management Software, Laboratory Information Management Systems (LIMS), Compliance And Audit Management Software

What Is The Driver Of The Cell Therapy Processing Market?

The rising number of cell therapy research activities is expected to propel the growth of the cell therapy processing market going forward. Cell therapy refers to the process of manufacturing therapeutic products derived from living cells to treat or manage various diseases, including cancers, autoimmune disorders, and genetic conditions. The demand for cell-based therapy is increasing due to the growing need for scalable and consistent manufacturing platforms that can support high cell densities without compromising product quality. Cell therapy processing is beneficial for cell therapy research, as it enables the standardized preparation, quality control, and scalable production of high-quality cells, ensuring reliable and reproducible outcomes for experimental and clinical studies. For instance, in December 2024, according to the International Federation of Pharmaceutical Manufacturers and Associations, a Switzerland-based non-profit organization, six first-in-class cell and gene treatments were introduced in 2023, which is 50% more than the three that were introduced in 2022. Therefore, the rising number of cell therapy research activities is driving the growth of the cell therapy processing industry.

Key Players In The Global Cell Therapy Processing Market

Major companies operating in the cell therapy processing market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Novartis AG, Gilead Sciences Inc., Danaher Corporation, Lonza Group AG, Anterogen Co. Ltd., Terumo Corporation, Sartorius AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, AGC Biologics S.p.A., MaxCyte Inc., Cellares Corporation, Cellectis S.A., JW Cayman Therapeutics Company Limited, Cell Therapies Pty Ltd., InGeneron Inc., WuXi Advanced Therapies, Catalent Inc.

Global Cell Therapy Processing Market Trends and Insights

Major companies operating in the cell therapy processing market are focusing on developing advanced solutions, such as integrated bioreactor-centrifuge systems, to streamline manufacturing workflows and improve the consistency, scalability, and sterility of cell-based therapies. An integrated bioreactor-centrifuge system is a unified device that combines cell incubation and centrifugal separation within a single closed unit, enabling continuous, automated cell processing without the need for intermediate transfers. For instance, in March 2025, Limula SA, a Switzerland-based company that manufactures cell and gene therapy (CGT), launched LimONE, an automated, closed-system platform for cell therapy manufacturing. This innovative system integrates hardware, single-use consumables, and protocol-driven software to streamline complex cell processing steps, such as incubation, centrifugation, and reagent handling, into a single compact unit, enabling consistent, scalable production of therapies such as CAR-T and gene-edited stem cells from research through to GMP-compliant manufacturing without the need for complex technology transfers.

What Are Latest Mergers And Acquisitions In The Cell Therapy Processing Market?

In May 2025, AstraZeneca PLC, a UK-based pharmaceutical company, acquired ESO Biotech for $1 billion. Through this acquisition, AstraZeneca aims to expand its rare disease portfolio by integrating ESO Biotech’s gene-editing technology to enhance its genomic medicine capabilities. ESO Biotech is a Belgium-based company that develops next-generation gene-editing therapies for rare diseases.

Regional Outlook

North America was the largest region in the cell therapy processing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Therapy Processing Market?

The cell therapy processing market consists of revenues earned by entities by providing services such as cell isolation, enrichment services, cell expansion, cryopreservation, and cell characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell therapy processing market also includes sales of cell culture bioreactors, cell counting analyzer, flow cytometers, and viral vector production systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Therapy Processing Market Report 2026?

The cell therapy processing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy processing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.